Dapoxetine Hydrochloride

盐酸达泊西汀

Report date: 2022/05/17 17:47:17
NME

Base Information

Drug NameDapoxetine Hydrochloride
Drug Alias Name达泊西汀盐酸盐dapoxetinadapoxetinum盐酸达波西汀达泊西汀 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsPremature EjaculationErectile DysfunctionSexual Dysfunction, Physiological
Global Approved IndicationsPremature Ejaculation
Approved Indications in ChinaPremature Ejaculation
Original Approved Country/TerritoryFinland
Original Approved Date2009/02/01
Country/TerritoryBelgiumCanadaUnited States +[16] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesBerlin-Chemie Ag (Menarini Group)Johnson & Johnson
Inactive CompaniesJanssen Research & Development LlcJohnson & Johnson Pharmaceutical Research & Development LLCAlza Corporation, De, Usa
Active IndicationsPremature Ejaculation
Inactive IndicationsErectile DysfunctionSexual Dysfunction, Physiological

Other Information

ATC CodeG04BX14
Related LinksWikipediaDrugBankKEGG